A disease-specific questionnaire for assessing quality of life in patients on hemodialysis
- PMID: 1565182
- DOI: 10.1159/000186769
A disease-specific questionnaire for assessing quality of life in patients on hemodialysis
Erratum in
- Nephron 1992;61(2):248
Abstract
A disease-specific questionnaire was developed for patients receiving chronic hemodialysis by interviewing patients to determine which aspects of their quality of life were adversely affected by their disease. The final questionnaire contained 26 questions in five dimensions (physical symptoms, fatigue, depression, relationships with others, frustration). The questionnaire demonstrated construct validity when compared with the Sickness Impact Profile, time trade-off technique and an exercise stress test. It was reproducible in stable, placebo-treated patients (correlation coefficient 0.85-0.98 for the 5 dimensions). It was more responsive than other measures in detecting an improvement with erythropoietin therapy in a randomized, placebo-controlled trial. This questionnaire should be useful for the assessment of the effect of various interventions upon the quality of life of hemodialysis patients.
Similar articles
-
Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group.BMJ. 1990 Mar 3;300(6724):573-8. doi: 10.1136/bmj.300.6724.573. BMJ. 1990. PMID: 2108751 Free PMC article. Clinical Trial.
-
The use of generic and specific quality-of-life measures in hemodialysis patients treated with erythropoietin. The Canadian Erythropoietin Study Group.Control Clin Trials. 1991 Aug;12(4 Suppl):168S-179S. doi: 10.1016/s0197-2456(05)80021-2. Control Clin Trials. 1991. PMID: 1663853 Clinical Trial.
-
A randomized double-blind study of recombinant human erythropoietin in anaemic hemodialysis patients. Canadian Erythropoietin Study Group.Transplant Proc. 1991 Apr;23(2):1825-6. Transplant Proc. 1991. PMID: 2053167 Clinical Trial.
-
[The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis].Urol Nefrol (Mosk). 1990 Nov-Dec;(6):69-70. Urol Nefrol (Mosk). 1990. PMID: 2089771 Review. Russian. No abstract available.
-
Management of the chronic renal failure patient receiving epoetin alfa for the treatment of anemia.Transplant Proc. 1991 Apr;23(2):1831-2. Transplant Proc. 1991. PMID: 2053169 Review. No abstract available.
Cited by
-
General health of end stage renal disease program beneficiaries.Health Care Financ Rev. 1997 Fall;19(1):121-44. Health Care Financ Rev. 1997. PMID: 10179995 Free PMC article.
-
Comparison of the course to end-stage renal disease of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic nephropathy.Diabetologia. 1993 Oct;36(10):1094-8. doi: 10.1007/BF02374504. Diabetologia. 1993. PMID: 8243860
-
Patient-reported outcome measures for life participation in patients with chronic kidney disease: a systematic review.Clin Kidney J. 2024 Nov 12;18(1):sfae341. doi: 10.1093/ckj/sfae341. eCollection 2025 Jan. Clin Kidney J. 2024. PMID: 39811258 Free PMC article.
-
Identifying core symptom clusters based on symptom distress levels in patients with maintenance hemodialysis: a cross-sectional network analysis.Ren Fail. 2025 Dec;47(1):2449203. doi: 10.1080/0886022X.2024.2449203. Epub 2025 Jan 13. Ren Fail. 2025. PMID: 39806785 Free PMC article.
-
Patient-Reported Outcome Measures for Adults With Kidney Disease: Current Measures, Ongoing Initiatives, and Future Opportunities for Incorporation Into Patient-Centered Kidney Care.Am J Kidney Dis. 2019 Dec;74(6):791-802. doi: 10.1053/j.ajkd.2019.05.025. Epub 2019 Sep 3. Am J Kidney Dis. 2019. PMID: 31492487 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical